Sigma Spectrum Infusion Pump Warning Issued Due to Risks Posed By Software Problems: FDA

Incorrect software installation could result in serious or life-threatening injuries, manufacturer warns.

Federal health officials have issued an early warning about a risk of problems with certain Baxter Sigma Spectrum infusion pumps, indicating that a software mismatch that may cause incorrect medication flow rates, potentially leading to serious or life-threatening harm.

The U.S. Food and Drug Administration (FDA) announced the Baxter Infusion Pump Software early alert on July 1, advising healthcare professionals to remove the affected pumps from service until the proper software is installed.

Spectrum infusion pumps are used to deliver IV fluids, blood and blood products under the supervision of a licensed physician or certified medical professional. The devices rely on software tailored to their specific platform, with the V6 and V8 models differing significantly in clinical workflow and user interface, including menu layouts and input requirements.

A software mismatch, such as installing V6 software on a V8 pump or vice versa, can lead to inaccurate flow rates and potentially confuse users trained on only one model. This can result in programming errors or delays in treatment.

Such errors may lead to under infusion, over infusion or interruptions in therapy, which can cause serious complications including drug toxicity, overdose, fluid overload, electrolyte imbalances or subtherapeutic dosing. The severity of risk depends on the medication, fluid involved and the patient’s condition.

The FDA’s safety warning applies to Baxter Sigma Spectrum Infusion System models V6 (product code 35700BAX) and V8 (product code 35700BAX2). A list of affected serial numbers is included in the agency’s early alert notice.

The alert was issued after Baxter identified a risk that incorrect software versions may have been installed on some devices. This mismatch can lead to inaccurate medication flow rates, particularly during extended use, posing serious safety concerns for patients.

On June 20, Baxter sent notification letters to impacted customers with the following instructions:

• Immediately remove any Spectrum pumps with affected serial numbers, located on the bottom of the device.
• Verify the software version installed. V6 pumps should use software beginning with “6,” while V8 pumps require software beginning with “8.” This information is viewable on the startup screen or within the device menu.
• Contact Baxter to confirm the installed software and arrange for service if necessary.
• Return the enclosed reply form to acknowledge receipt of the letter, even if no affected units remain in inventory.
• Distribute the alert to all departments or facilities using the affected infusion pumps.

As of July 1, no injuries or fatalities have been reported. However, the FDA has classified the affected devices as high risk, particularly for vulnerable patients who may be more susceptible to complications from infusion errors.

To verify software versions or request service, customers can contact Baxter Global Technical Services at 800-843-7867, Monday through Friday, 7 a.m. to 7 p.m. ET or email corporate_product_complaints_round_lake@baxter.com.

Healthcare professionals and consumers may also report adverse reactions or device malfunctions to the FDA Safety Information and Adverse Event Reporting Program.